This site is still under development. Information, features, and some organizational
aspects of the data still need further work and will change as we continue building.

Yondelis

Hover over a term you want explained. If you need more details, then click on the term and a new tab will open with a full details page.

What Yondelis Means in Everyday Medical Language

Yondelis is the brand name for a chemotherapy drug also called trabectedin, ecteinascidin, or ET 743. It is used to treat certain rare cancers called soft tissue sarcomas, specifically liposarcoma and leiomyosarcoma. These cancers affect connective tissues such as fat, muscle, or fibrous tissue. Yondelis works by damaging the DNA inside cancer cells, which helps stop them from growing and dividing.

Why Yondelis Can Matter in Cancer Care

This drug offers an important treatment option for patients whose soft tissue sarcomas cannot be removed by surgery or have spread to other parts of the body. It is usually given after other chemotherapy drugs, like anthracyclines, have been tried. Yondelis may help control the cancer and improve quality of life when other treatments have been used. Researchers are also studying its use in other cancers, which may expand its role in cancer care in the future.

What Patients Might See or Hear About Yondelis

Patients and caregivers might encounter the term Yondelis or its other names—trabectedin, ecteinascidin, or ET 743—in medical records, treatment plans, or discussions with their healthcare team. It may also appear on clinical trial listings or drug information pages. Because the drug has several names, it’s helpful to confirm with the care team exactly what the term means in the context of the patient’s care.

What Yondelis Does Not Automatically Mean

Seeing the name Yondelis does not mean a diagnosis or treatment plan is set in stone. It is the name of a drug, not a diagnosis or a guarantee of effectiveness. The decision to use this drug depends on many factors, including the type and stage of cancer, previous treatments, and the patient’s overall health. It’s important not to assume that just because the drug is mentioned, it will be part of the patient’s care without a detailed discussion with the healthcare team.

Common Questions to Ask Your Care Team

If Yondelis comes up in your care, you might ask: What is this drug expected to do for my cancer? How does it compare to other treatments I’ve had? What side effects should I watch for? Are there clinical trials involving this drug that might be right for me? Understanding how this drug fits into your overall treatment plan can help you feel more informed and involved in your care.

How to Read the Term in Context

Because Yondelis has multiple names and is often used after other chemotherapy drugs, it’s important to read it in the context of your medical records or treatment discussions. Always ask your care team to explain what the term means for your specific situation rather than relying on the word alone. This helps avoid confusion and ensures you get accurate information tailored to your care.

Safety and Next Steps

This information is meant to educate and does not replace medical advice. Only your healthcare team can decide if Yondelis is safe or appropriate for you. If you see this term in your records or hear it mentioned, the best next step is to ask your doctor or nurse what it means in your exact report, test result, treatment plan, or symptom discussion.

Sources

Public source information used for this glossary entry includes: